27th Apr 2017 2:10 pm |
RNS |
Results of Annual General Meeting |
7th Apr 2017 7:00 am |
RNS |
Pre-clinical Data Presented at AACR |
31st Mar 2017 7:00 am |
RNS |
Total Voting Rights |
29th Mar 2017 8:07 am |
RNS |
Vesting of LTIP awards |
28th Mar 2017 11:00 am |
RNS |
Grant of Share Options under Share Option Scheme |
27th Mar 2017 7:00 am |
RNS |
2016 Annual Report and Notice of AGM |
24th Mar 2017 7:00 am |
RNS |
Appointment of Director |
21st Mar 2017 10:08 am |
RNS |
Chi-Med to host R&D Briefings |
20th Mar 2017 8:04 am |
RNS |
Directors' Share Dealing |
16th Mar 2017 11:25 am |
RNS |
Grant of Awards under Long Term Incentive Plan |
13th Mar 2017 7:00 am |
RNS |
Publication of Form 20-F |
13th Mar 2017 7:00 am |
RNS |
Final Results |
10th Mar 2017 8:11 am |
RNS |
Sulfatinib Phase Ib/II Results Presented at ENETS |
10th Mar 2017 7:18 am |
RNS |
Sulfatinib Phase Ib/II Results Presented at ENETS |
7th Mar 2017 11:49 am |
EQS |
Edison issues update on Hutchison China Meditech (HCM) |
3rd Mar 2017 7:00 am |
RNS |
Positive Fruquintinib Pivotal Phase III Results |
28th Feb 2017 10:20 am |
RNS |
Change of Directors |
20th Feb 2017 7:00 am |
RNS |
Start of Phase II Savolitinib PSC trial in China |
14th Feb 2017 7:07 am |
RNS |
Initiates Phase I of Novel FGFR Inhibitor HMPL-453 |
14th Feb 2017 7:00 am |
RNS |
Savolitinib PRCC Results Presentation at ASCO GU |
6th Feb 2017 7:00 am |
RNS |
Chi-Med to Announce 2016 Final Results |
1st Feb 2017 7:00 am |
RNS |
Change of Directors |
16th Jan 2017 10:48 am |
RNS |
Change of Directors |
16th Jan 2017 10:11 am |
RNS |
Change of Directors |
16th Jan 2017 7:30 am |
RNS |
Fruquintinib Phase I/II Clinical Data at ASCO GI |
16th Jan 2017 7:29 am |
RNS |
Sulfatinib Phase II Study in 2nd Line BTC in China |
16th Jan 2017 7:16 am |
RNS |
Fruquintinib Combination Study in 1st-Line NSCLC |
10th Jan 2017 7:00 am |
RNS |
Chi-Med Initiates HMPL-523 Clinical Trials |
30th Dec 2016 9:11 am |
RNS |
Total Voting Rights |
29th Dec 2016 7:40 am |
RNS |
Blocklisting Six Monthly Return |
20th Dec 2016 7:18 am |
RNS |
Director's Share Dealing |
14th Dec 2016 7:14 am |
RNS |
Director's Share Dealing |
6th Dec 2016 7:00 am |
RNS |
HMPL-523 Pre-clinical Data Presented at ASH |
30th Nov 2016 7:51 am |
RNS |
Exercise of Share Options |
30th Nov 2016 7:48 am |
RNS |
Total Voting Rights |
23rd Nov 2016 7:34 am |
RNS |
Director's Share Dealing |
23rd Nov 2016 7:30 am |
RNS |
Chi-Med to Present Data at the 17th WCLC |
23rd Nov 2016 7:08 am |
RNS |
Chi-Med to Present Data at the at the 17th WCLC |
14th Nov 2016 9:06 am |
RNS |
Chi-Med Presents Ph I Clinical Data for HMPL-523 |
1st Nov 2016 2:57 pm |
RNS |
Director's Share Dealing |